May 6, 2020
PinCell in refreshing management and board of directors
PinCell has added new members to its management team and the board of directors following a successful seed funding led by Sofinnova Partners
pharmaceutical daily
Pharmaceuticals, Biotechnology and Life Sciences
May 6, 2020
Transgene posts €35.3 million in cash and cash equivalents in Q1 2020
Transgene posts €35.3 million in cash and cash equivalents in Q1 2020, with minor impact from the Covid-19 pandemic seen to-date
May 6, 2020
DongWha Pharm’s plans testing new drug candidate to treat COVID-19
DongWha Pharm’s said it is getting ready for second phase of clinical trials of new drug candidate DW2008 to treat COVID-19.
May 6, 2020
Cabaletta Bio Receives FDA Fast Track Designation for DSG3-CAART for the Treatment of Mucosal Pemphigus Vulgaris
PHILADELPHIA–(BUSINESS WIRE)–Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery and development of engineered T cell…
May 6, 2020
Alnylam Pharmaceuticals ends Q1 2020 with net product revenues of $71.94M
Alnylam Pharmaceuticals ends Q1 2020 with net product revenues of $71.94M
May 6, 2020
Axcella gets positive data from AXA1125-003 study
Clinically relevant reductions in liver fat content, insulin resistance and fibroinflammation markers observed with AXA1125 along with favorable tolerability, supporting…
May 6, 2020
Spruce Biosciences has new CFO and new VP pharma development and manufacturing
Spruce Biosciences has announced the appointments of Samir Gharib, MBA, CPA, as Chief Financial Officer (CFO), and Dasharatha Reddy, Ph.D., as Vice President, Pharmaceutical Development and Manufacturing.
May 6, 2020
Acerus’s Norma Beauchamp in resignation as director
TORONTO–(BUSINESS WIRE)–Acerus Pharmaceuticals Corporation (TSX:ASP, OTCQB:ASPCF) (“Acerus” or the “Company”) announced that Norma Beauchamp has resigned as a member of…
May 6, 2020
PharmaCyte Biotech Receives Medical Devices Registration and Submits Pre-EUA Application to the FDA for COVID-19 Diagnostic Kit
LAGUNA HILLS, Calif.–(BUSINESS WIRE)–#INDstatus–PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes…
May 6, 2020
Ventus Therapeutics Launches with $60 Million Series A
Founded by Versant Ventures to develop medicines that target the innate immune system WALTHAM, Mass. & MONTREAL–(BUSINESS WIRE)–Ventus Therapeutics Inc.…